Pluripotent Anti-Inflammatory Modulators for Chronic Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Classical anti-inflammatory drugs are ineffective or have adverse effects in treating chronic diseases such as cardiovascular disease, type 2 diabetes, chronic kidney disease, Alzheimer's disease, and cancer, and there is a need for effective treatments for low-grade chronic inflammation underlying these conditions.
Innovation Solution
Administration of a therapeutically effective amount of a compound of Formula I or its pharmaceutically acceptable salt, potentially combined with secondary therapeutic agents, to treat inflammatory conditions, including tissue and organ transplant rejections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If classical anti-inflammatory drugs (NSAIDs and SAIDs) are used to treat inflammation, then inflammation is reduced, but adverse effects occur and no benefit is shown in treating chronic diseases
Solution Approach 1:
The patent changes the chemical structure parameters of anti-inflammatory compounds by introducing specific substituents (R1-R6 groups) at defined positions on the core structure, creating novel compounds with modified pharmacological properties that reduce adverse effects while maintaining anti-inflammatory activity
Solution Approach 2:
The patent creates composite molecular structures combining a core chemical framework with various functional groups and substituents, where the composite structure provides both anti-inflammatory efficacy and improved safety profile compared to classical drugs
2Object-affected harmful factors
If classical anti-inflammatory drugs are used, then inflammation is treated, but effectiveness in chronic diseases is lacking
Solution Approach 1:
The patent modifies key pharmacological parameters of anti-inflammatory agents through systematic variation of molecular substituents, creating compounds with enhanced efficacy for chronic disease treatment while maintaining acceptable safety profiles
3Object-generated harmful factors
If no anti-inflammatory treatment is used for chronic diseases, then adverse effects are avoided, but the underlying inflammation is not treated
Solution Approach 1:
The patent introduces novel chemical compounds as intermediary substances that mediate between the need for anti-inflammatory action and the avoidance of adverse effects, providing a bridge therapy that treats chronic inflammation without the severe side effects of classical drugs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound effectively inhibits NF-κB-dependent gene expression, induces phase two enzymes, inhibits the inflammasome, and promotes AMPK phosphorylation, reducing inflammation and improving conditions like insulin resistance and prolonging organ graft survival.
Implementation Method 1
The compound effectively inhibits NF-κB-dependent gene expression
Implementation Method 2
induces phase two enzymes
Implementation Method 3
inhibits the inflammasome
Implementation Method 4
promotes AMPK phosphorylation
Data Source
AI summary
Methods of treating acute and chronic inflammatory conditions, tissue transplant rejection, and/or organ transplant rejection comprising administering to a subject in need thereof a therapeutically effective amount of a pluripotent anti-inflammatory and metabolic modulators optionally in combination with one or more secondary therapeutic agents and pharmaceutical compositions thereof.